{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:56:31Z","timestamp":1791284191707,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77185-0","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T17:01:55Z","timestamp":1729962115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nail changes in patients receiving systemic isotretinoin therapy"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7783-0457","authenticated-orcid":false,"given":"Dilek","family":"Yigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1628","authenticated-orcid":false,"given":"Nermin","family":"Karaosmanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"77185_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000246717","volume":"190","author":"V Goulden","year":"1995","unstructured":"Goulden, V., Layton, A. M. & Cunliffe, W. J. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology. 190, 284\u2013287. https:\/\/doi.org\/10.1159\/000246717 (1995).","journal-title":"Dermatology"},{"key":"77185_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/bjd.15668","volume":"178","author":"IA Vallerand","year":"2018","unstructured":"Vallerand, I. A. et al. Efficacy and adverse events of oral isotretinoin for acne: A systematic review. Br. J. Dermatol. 178, 76\u201385. https:\/\/doi.org\/10.1111\/bjd.15668 (2018).","journal-title":"Br. J. Dermatol."},{"key":"77185_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1067\/mjd.2001.113717","volume":"45","author":"CN Ellis","year":"2001","unstructured":"Ellis, C. N. & Krach, K. J. Uses and complications of isotretinoin therapy. J. Am. Acad. Dermatol. 45, 150\u2013157. https:\/\/doi.org\/10.1067\/mjd.2001.113717 (2001).","journal-title":"J. Am. Acad. Dermatol."},{"key":"77185_CR4","doi-asserted-by":"publisher","unstructured":"Elias, P. M. Retinoid effects on the epidermis. Dermatologica. 175(Suppl 1), 28\u201336 https:\/\/doi.org\/10.1159\/000248851  (1987).","DOI":"10.1159\/000248851"},{"key":"77185_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/ijd.15635","volume":"60","author":"S Ozcelik","year":"2021","unstructured":"Ozcelik, S. & Kilic, F. A. Effects of isotretinoin on the growth rate and thickness of the nail plate. Int. J. Dermatol. 60, 1258\u20131262. https:\/\/doi.org\/10.1111\/ijd.15635 (2021).","journal-title":"Int. J. Dermatol."},{"key":"77185_CR6","doi-asserted-by":"publisher","unstructured":"Piraccini, B. M. & Iorizzo, M. Drug reactions affecting the nail unit: diagnosis and management. Dermatol. Clin. 25, 215\u2009\u2013\u200921, vii. https:\/\/doi.org\/10.1016\/j.det.2007.01.006 (2007).","DOI":"10.1016\/j.det.2007.01.006"},{"key":"77185_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bjd.20882","volume":"186","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: An analysis from the global burden of disease study 2019. Br. J. Dermatol. 186, 673\u2013683. https:\/\/doi.org\/10.1111\/bjd.20882 (2022).","journal-title":"Br. J. Dermatol."},{"key":"77185_CR8","doi-asserted-by":"publisher","unstructured":"Zaenglein, A. L. et al. Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74, 945\u2009\u2013\u200973 e3.  https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037 (2016).","DOI":"10.1016\/j.jaad.2015.12.037"},{"key":"77185_CR9","first-page":"367","volume":"109","author":"R Baran","year":"1982","unstructured":"Baran, R. Therapeutic assessment and side-effects of the aromatic retinoid on the nail apparatus. Ann. Dermatol. Venereol. 109, 367\u2013371 (1982).","journal-title":"Ann. Dermatol. Venereol."},{"key":"77185_CR10","doi-asserted-by":"publisher","unstructured":"Allegue, F., Gonzalez-Vilas, D. &  Zulaica, A. Isotretinoin-induced elkonyxis Actas Dermosifiliogr. 108, 166\u2013167. https:\/\/doi.org\/10.1016\/j.ad.2016.08.007 (2017).","DOI":"10.1016\/j.ad.2016.08.007"},{"key":"77185_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/15569527.2014.902380","volume":"35","author":"N Alli","year":"2016","unstructured":"Alli, N. & Dogan, S. Short-term isotretinoin-induced elkonyxis and median nail dystrophy. Cutan. Ocul Toxicol. 35, 85\u201386. https:\/\/doi.org\/10.3109\/15569527.2014.902380 (2016).","journal-title":"Cutan. Ocul Toxicol."},{"key":"77185_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3315\/jdcr.2011.1062","volume":"5","author":"K Armstrong","year":"2011","unstructured":"Armstrong, K. & Weinstein, M. Pyogenic granulomas during isotretinoin therapy. J. Dermatol. Case Rep. 5, 5\u20137. https:\/\/doi.org\/10.3315\/jdcr.2011.1062 (2011).","journal-title":"J. Dermatol. Case Rep."},{"key":"77185_CR13","first-page":"32","volume":"12","author":"C Benedetto","year":"2019","unstructured":"Benedetto, C., Crasto, D., Ettefagh, L. & Nami, N. Development of periungual pyogenic granuloma with associated paronychia following isotretinoin therapy: A case report and a review of the literature. J. Clin. Aesthet. Dermatol. 12, 32\u201336 (2019).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"77185_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2133.1992.tb00472.x","volume":"127","author":"WW Bottomley","year":"1992","unstructured":"Bottomley, W. W. & Cunliffe, W. J. Median nail dystrophy associated with isotretinoin therapy. Br. J. Dermatol. 127, 447\u2013448. https:\/\/doi.org\/10.1111\/j.1365-2133.1992.tb00472.x (1992).","journal-title":"Br. J. Dermatol."},{"key":"77185_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1590\/abd1806-4841.20163817","volume":"91","author":"A Figueiras Dde","year":"2016","unstructured":"Figueiras Dde, A., Ramos, T. B., Marinho, A. K., Bezerra, M. S. & Cauas, R. C. Paronychia and granulation tissue formation during treatment with isotretinoin. Bras. Dermatol. 91, 223\u2013225. https:\/\/doi.org\/10.1590\/abd1806-4841.20163817 (2016).","journal-title":"Bras. Dermatol."},{"key":"77185_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/jdv.12819","volume":"30","author":"S Gregoriou","year":"2016","unstructured":"Gregoriou, S., Banaka, F. & Rigopoulos, D. Isotretinoin-induced transverse leuconychia. J. Eur. Acad. Dermatol. Venereol. 30, 385\u2013386. https:\/\/doi.org\/10.1111\/jdv.12819 (2016).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"77185_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/095466301317085426","volume":"12","author":"M Onder","year":"2001","unstructured":"Onder, M., Oztas, M. O. & Oztas, P. Isotretinoin-induced nail fragility and onycholysis. J. Dermatolog Treat. 12, 115\u2013116. https:\/\/doi.org\/10.1080\/095466301317085426 (2001).","journal-title":"J. Dermatolog Treat."},{"key":"77185_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2133.2005.06782.x","volume":"153","author":"A Yung","year":"2005","unstructured":"Yung, A., Johnson, P. & Goodfield, M. J. Isotretinoin-induced elkonyxis. Br. J. Dermatol. 153, 671\u2013672. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06782.x (2005).","journal-title":"Br. J. Dermatol."},{"key":"77185_CR19","doi-asserted-by":"publisher","unstructured":"Brzezinski, P., Borowska, K., Chiriac, A. & Smigielski, J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol. Ther. 30. https:\/\/doi.org\/10.1111\/dth.12483 (2017).","DOI":"10.1111\/dth.12483"},{"key":"77185_CR20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","volume":"149","author":"RC Blasiak","year":"2013","unstructured":"Blasiak, R. C., Stamey, C. R., Burkhart, C. N., Lugo-Somolinos, A. & Morrell, D. S. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 149, 1392\u20131398. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6746 (2013).","journal-title":"JAMA Dermatol."},{"key":"77185_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1590\/s0365-05962010000300006","volume":"85","author":"F Brito Mde","year":"2010","unstructured":"Brito Mde, F., Sant\u2019Anna, I. P., Galindo, J. C., Rosendo, L. H. & Santos, J. B. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin. Bras. Dermatol. 85, 331\u2013337. https:\/\/doi.org\/10.1590\/s0365-05962010000300006 (2010).","journal-title":"Bras. Dermatol."},{"key":"77185_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","volume":"51","author":"M Rademaker","year":"2010","unstructured":"Rademaker, M. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J. Dermatol. 51, 248\u2013253. https:\/\/doi.org\/10.1111\/j.1440-0960.2010.00657.x (2010).","journal-title":"Australas J. Dermatol."},{"key":"77185_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09546634.2016.1230175","volume":"28","author":"DD Demirseren","year":"2017","unstructured":"Demirseren, D. D. et al. The weeks and the cumulative doses of the first adverse events related to oral isotretinoin in acne patients: Analysis of 300 patients. J. Dermatol. Treat. 28, 309\u2013313. https:\/\/doi.org\/10.1080\/09546634.2016.1230175 (2017).","journal-title":"J. Dermatol. Treat."},{"key":"77185_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1574886317666220613162225","volume":"18","author":"L Legiawati","year":"2023","unstructured":"Legiawati, L., Fahira, A., Taufiqqurrachman, I., Arifin, G. R. & Widitha, U. R. Low-dose versus conventional-dose oral isotretinoin regimens: A systematic review on randomized controlled comparative studies of different regimens. Curr. Drug Saf. 18, 297\u2013306. https:\/\/doi.org\/10.2174\/1574886317666220613162225 (2023).","journal-title":"Curr. Drug Saf."},{"key":"77185_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2133.1994.tb08524.x","volume":"131","author":"V Goulden","year":"1994","unstructured":"Goulden, V., Layton, A. M. & Cunliffe, W. J. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br. J. Dermatol. 131, 360\u2013363. https:\/\/doi.org\/10.1111\/j.1365-2133.1994.tb08524.x (1994).","journal-title":"Br. J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77185-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T17:07:32Z","timestamp":1729962452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77185"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77185-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25561"}}